Dave Neal

Dave Neal is the founder of Belhaven BioPharma, Inc., founded in 2021, where the title held is Chief Financial Officer & Director.
Current jobs include Managing Director at Accelerant Ventures LLC since 2017 and Venture Partner at Duke Capital Partners since 2018.
Former jobs include CEO at Crispin Corp.
from 2004 to 2009; President & Chief Executive Officer at GMA Healthcare Ltd. from 2009 to 2011; Chairman at Infina Connect Healthcare Systems, Inc. from 2010 to 2012; Director at PatientPay, Inc. from 2011 to 2012; Managing Director at Accelerant Management LLC from 2012 to 2016; VP Finance at Travel Dynamics, Inc. from 1989 to 1992; Chief Financial Officer & Counsel at Bloodhound Software, Inc. from 2002 to 2004; Vice President-Finance & Counsel at Intrasoft Ltd. from 1996 to 1999; Chief Financial Officer & General Counsel at Citect, Inc. from 1994 to 1995; Vice President-Finance & Administration at Plurimus Corp.
from 2000 to 2001; VP Business Development at Seagate Software Network & Systems Management Group Inc from 1995 to 1996; Member at CI Partners LLC from 1995 to 1996; Regional Manager at CIS Capital Equipment Partners from 1986 to 1989.
Education includes an MBA from Stanford Graduate School of Business in 1986, graduate degree from UNC School of Law in 1981, and undergraduate degree from the University of North Carolina at Chapel Hill in 1978.